Top

Published in:

01-02-2019 | Oncology | Original Article

The Current Status of Peritoneal Surface Oncology in Saudi Arabia

Authors: Mohammad Alyami, Frederic Mercier, Thamer Bin Traiki, Nora Trabulsi, Ihssan Al-Alem, Abdulaziz Alzahrani, Mashhour Alqannas, Khalid Almohaimeed

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2019

Abstract

Peritoneal carcinomatosis (PC) is a common evolution of abdominal cancers. It may arise from the peritoneum itself (primary) or originate from another type of cancer especially those of gastrointestinal or gynecological origin (secondary). Without aggressive multimodal therapeutic approaches, PC is associated with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used to treat PC since 1990. In Saudi Arabia, the first CRS and HIPEC were done in 2008. In 2018, Saudi Arabia population is 32 millions of people and the demand for such procedures has grown up. This article gives outlines of the current status of peritoneal surface oncology in Saudi Arabia and the future perspective.

Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363CrossRefPubMed

Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P (1989) Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16(4 Suppl 6):83–97PubMed

Gilly FN, Sayag AC, Carry PY, Braillon GG, James IM, Volloch AA, Panteix GG (1991) Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report. Int Surg 76(3):164–167PubMed

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRefPubMed

Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237–6242CrossRefPubMed

Goere D, Malka D, Tzanis D, Gava V, Boige V, Eveno C et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071CrossRefPubMed

Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K et al (2016) Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23(6):1971–1979CrossRefPubMed

Saudi Cancer Registry (2015) Saudi Arabia cancer incidence report 2012. Saudi Cancer Registry, Riyadh

Al-Hanawi MK (2017) The healthcare system in Saudi Arabia: how can we best move forward with funding to protect equitable and accessible care for all? Int J Healthc 3(2):78CrossRef

10.

Sebai ZAMW, Al-Zulaibani AA (2001) Health care services in Saudi Arabia: past, present and future. J Family Community Med 8(3):19–23PubMedPubMedCentral

Title: The Current Status of Peritoneal Surface Oncology in Saudi Arabia
Authors: Mohammad Alyami
Frederic Mercier
Thamer Bin Traiki
Nora Trabulsi
Ihssan Al-Alem
Abdulaziz Alzahrani
Mashhour Alqannas
Khalid Almohaimeed
Publication date: 01-02-2019
Publisher: Springer India
Keywords: Oncology
Peritoneal Cancer
Peritoneal Carcinomatosis
Published in: Indian Journal of Surgical Oncology / Issue Special Issue 1/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-019-00876-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Current Status of Peritoneal Surface Oncology in Saudi Arabia

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2019

Management of Peritoneal Surface Malignancies in Pakistan

Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel

Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication—a Retrospective Study by INDEPSO

Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC—a Retrospective Study by INDEPSO

Preface ‘Changing Trend in Peritoneal Surface Oncology in Asian Countries’

Chasing Rainbows? the Possibility of “Cure” in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC—a Retrospective Study by INDEPSO